Status:
COMPLETED
PET-CT Based Radiotherapy in Esophageal Cancer Patients
Lead Sponsor:
Maastricht Radiation Oncology
Conditions:
Esophageal Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the locoregional control in PET/CT based radiotherapy treatment planning in the treatment of esophageal cancer patients.
Detailed Description
The purpose of this study is to determine the locoregional control in PET/CT based radiotherapy treatment planning in the treatment of esophageal cancer patients
Eligibility Criteria
Inclusion
- Histologically proven adenocarcinoma or squamous cell carcinoma of the esophagus
- Local curable disease able to undergo Chemoradiotherapy.
Exclusion
- Metastasized disease.
- Previous or concurrent malignancies.
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT01156831
Start Date
November 1 2007
End Date
May 1 2013
Last Update
December 8 2014
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Atrium Hospital
Heerlen, Netherlands
2
University Medical Center
Maastricht, Netherlands
3
St. Laurentius Hospital
Roermond, Netherlands
4
Maasland Hospital
Sittard, Netherlands